SJ Machin

871 total citations
29 papers, 652 citations indexed

About

SJ Machin is a scholar working on Hematology, Rheumatology and Genetics. According to data from OpenAlex, SJ Machin has authored 29 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 10 papers in Rheumatology and 4 papers in Genetics. Recurrent topics in SJ Machin's work include Systemic Lupus Erythematosus Research (10 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). SJ Machin is often cited by papers focused on Systemic Lupus Erythematosus Research (10 papers), Platelet Disorders and Treatments (7 papers) and Blood Coagulation and Thrombosis Mechanisms (5 papers). SJ Machin collaborates with scholars based in United Kingdom, United States and New Zealand. SJ Machin's co-authors include Hannah Cohen, Chris Gardiner, IJ Mackie, Jeffrey M. Hills, Alan Manning, Francis Green, Ian Mackie, T. McNally, Sarah L. Cohen and David Isenberg and has published in prestigious journals such as Intensive Care Medicine, Journal of Clinical Pathology and Thrombosis and Haemostasis.

In The Last Decade

SJ Machin

28 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
SJ Machin United Kingdom 17 252 223 133 126 87 29 652
Cynthia Rutherford United States 18 123 0.5× 326 1.5× 107 0.8× 223 1.8× 81 0.9× 35 1.1k
Shayna Sarosiek United States 16 87 0.3× 247 1.1× 114 0.9× 149 1.2× 104 1.2× 109 1.1k
Alí Duarte‐García United States 20 844 3.3× 295 1.3× 129 1.0× 99 0.8× 53 0.6× 71 1.2k
Michel Pavic France 14 71 0.3× 121 0.5× 113 0.8× 16 0.1× 46 0.5× 96 901
Cristina Santoro Italy 21 107 0.4× 1.2k 5.6× 116 0.9× 50 0.4× 76 0.9× 106 1.5k
Wim Terpstra Netherlands 18 43 0.2× 542 2.4× 115 0.9× 26 0.2× 65 0.7× 36 1.0k
Antoni Riera‐Mestre Spain 15 135 0.5× 135 0.6× 173 1.3× 11 0.1× 272 3.1× 58 829
Andrew I Rutherford United Kingdom 13 303 1.2× 116 0.5× 88 0.7× 38 0.3× 14 0.2× 31 639
Penny Ballem Canada 12 67 0.3× 747 3.3× 93 0.7× 91 0.7× 42 0.5× 18 919
Mohamad A. Kalot United States 10 34 0.1× 437 2.0× 127 1.0× 17 0.1× 156 1.8× 23 797

Countries citing papers authored by SJ Machin

Since Specialization
Citations

This map shows the geographic impact of SJ Machin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Machin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Machin more than expected).

Fields of papers citing papers by SJ Machin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SJ Machin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Machin. The network helps show where SJ Machin may publish in the future.

Co-authorship network of co-authors of SJ Machin

This figure shows the co-authorship network connecting the top 25 collaborators of SJ Machin. A scholar is included among the top collaborators of SJ Machin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SJ Machin. SJ Machin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Menegatti, Marzia, et al.. (2014). In vitro characterizations of the first therapeutic factor V concentrate. 2 indexed citations
2.
Romay‐Penabad, Zurina, et al.. (2014). Complement C5-inhibitor rEV576 (coversin) ameliorates in-vivo effects of antiphospholipid antibodies. Lupus. 23(12). 1324–1326. 26 indexed citations
3.
Westwood, John‐Paul, et al.. (2013). Complement activation in thrombotic thrombocytopenic purpura. Molecular Immunology. 56(3). 273–273. 1 indexed citations
4.
Mackie, IJ, et al.. (2011). Discrepancies between different types of ADAMTS13 assays in patients with thrombotic microangiopathies. UCL Discovery (University College London).
5.
Machin, SJ, et al.. (2010). Vaginal lichen planus: preservation of sexual function in severe disease. BMJ Case Reports. 2010. bcr0820092208–bcr0820092208. 10 indexed citations
6.
Machin, SJ, et al.. (2009). Persistent high factor VIII activity leading to increased thrombin generation. UCL Discovery (University College London). 1 indexed citations
7.
Briggs, Carol, et al.. (2009). Measurement of CD4+ T cells in point‐of‐care settings with the Sysmex pocH‐100i haematological analyser. International Journal of Laboratory Hematology. 31(2). 169–179. 5 indexed citations
8.
Al‐Ismail, Saad, et al.. (2008). Two-centre evaluation of the Abbott CD3500 blood counter. Clinical & Laboratory Haematology. 17(1). 11–21. 4 indexed citations
9.
Starke, Richard, Paul Harrison, Ian Mackie, et al.. (2005). The expression of prion protein (PrPC) in the megakaryocyte lineage. Journal of Thrombosis and Haemostasis. 3(6). 1266–1273. 24 indexed citations
11.
Bennett‐Guerrero, Elliott, Yi‐Ju Li, H. Wakeling, et al.. (1999). Hextend (R), a physiologically balanced plasma expander for large volume use in major surgery: A randomized phase III clinical trial. UCL Discovery (University College London). 59 indexed citations
12.
Purdy, G., et al.. (1998). The sensitivity and specificity of reagents for lupus anticoagulant testing vary between photo-optical and mechanical coagulometers.. UCL Discovery (University College London). 1 indexed citations
13.
İnanç, Murat, S Donohoe, C T Ravirajan, et al.. (1998). Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.. PubMed. 37(10). 1089–94. 38 indexed citations
14.
Salmon, J, Rebecca Cardigan, Ian Mackie, et al.. (1997). Continuous venovenous haemofiltration using polyacrylonitrile filters does not activate contact system and intrinsic coagulation pathways. Intensive Care Medicine. 23(1). 38–43. 42 indexed citations
15.
Green, Francis, SJ Machin, & Alan Manning. (1996). THE EMPLOYER SIZE-WAGE EFFECT: CAN DYNAMIC MONOPSONY PROVIDE AN EXPLANATION?. Oxford Economic Papers. 48(3). 433–455. 61 indexed citations
16.
Chitolie, A, et al.. (1995). THROMBOPLASTIN DEPENDENCE OF THE PT-DERIVED FIBRINOGEN ASSAY. UCL Discovery (University College London). 1 indexed citations
17.
Singer, Maxine, T. McNally, Gavin Screaton, et al.. (1994). Heparin clearance during continuous veno-venous haemofiltration. Intensive Care Medicine. 20(3). 212–215. 41 indexed citations
18.
Rivers, R P, James J. Walker, SJ Machin, et al.. (1993). GUIDELINES ON THE PREVENTION, INVESTIGATION AND MANAGEMENT OF THROMBOSIS ASSOCIATED WITH PREGNANCY. 17 indexed citations
19.
McNally, T., IJ Mackie, David Isenberg, & SJ Machin. (1993). Immunoelectrophoresis and ELISA techniques for assay of plasma β2 glycoprotein-i and the influence of plasma lipids. Thrombosis Research. 72(4). 275–286. 29 indexed citations
20.
Bounds, W, et al.. (1990). Changes in metabolism induced by oral contraceptives containing desogestrel and gestodene in older women. Contraception. 42(3). 263–273. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026